Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat i zdolność do wyrażenia świadomej zgody na udział w badaniu
- •Potwierdzony przez badanie mikroskopowe rozpoznanie chłoniaka (bez Hodgkina, z Hodgkina lub białaczki limfocytowej)
- •Mierzalne ogniska choroby widoczne w badaniach obrazowych
- •Wcześniejsze leczenie minimum dwoma innymi metodami lub brak możliwości standardowego leczenia
- •Dla niektórych typów chłoniaków: wcześniejsza terapia CAR-T i nawrót choroby po co najmniej 30 dniach
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- September 15, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
City of Hope
Duarte, United States
University of Colorado
Aurora, United States
Colorado Blood Cancer Institute (Sarah Cannon)
Denver, United States
University of Kansas Medical Center
Kansas City, United States
Cornell
New York, United States
Sarah Cannon Research Institute at St. David's South Austin
Austin, United States
University of Wisconsin Carbone Cancer Center
Madison, United States
Trial contact
Juan Vera, MD
Patricia Allison
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/16/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.